Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares?

57,180 shares were sold for a total transaction value of approximately ~$826,000 across multiple days ending April 16, 2026. This sale represented 12.29% of Rubinstein's direct holdings at the time, reducing her directly held Common Stock to 408,160 shares.